Immediate and long-term outcome of left-sided infective endocarditis. A 12-year prospective study from a contemporary cohort in a referral hospital

Clinical Microbiology and Infection

Volumn 18, Issue 12, 2012, Pages

  Fernandez Hidalgo N ^a,b,c   Almirante, B ^a,b,c   Tornos, P ^a,b,c   Gonzalez Alujas M T ^a,b,c   Planes, A M ^a,c   Galinanes M ^a,c   Pahissa, A ^a,b,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Endocarditis; Mortality; Prognosis; Recurrence; Relapse

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; DEATH; DENSITY; FEMALE; FOLLOW UP; HEART VALVE PROSTHESIS; HUMAN; LEFT SIDED INFECTIVE ENDOCARDITIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; SURVIVOR;

EID: 84869113752     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12033     Document Type: Article

References (34)

1. Galvez-Acebal J, Rodriguez-Bano J, Martinez-Marcos FJ et al. Prognostic factors in left-sided endocarditis: results from the Andalusian multicenter cohort. BMC Infect Dis 2010; 10: 17.
2. Selton-Suty C, Célard M, Le Moing V et al. Preeminence of Staphylococcus aureus in Infective endocarditis: a 1-year population-based survey. Clin Infect Dis 2012; 54: 1230-1239.
3. Murdoch DR, Corey GR, Hoen B et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med 2009; 169: 463-473.
4. Fernandez-Hidalgo N, Almirante B, Tornos P et al. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis 2008; 47: 1287-1297.
5. San Roman JA, Lopez J, Vilacosta I et al. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am J Med 2007; 120: 369.e1-369.e7.
6. Lopez J, Fernandez-Hidalgo N, Revilla A et al. Internal and external validation of a model to predict adverse outcomes in patients with left-sided infective endocarditis. Heart 2011; 97: 1138-1142.
7. Skehan JD, Murray M, Mills PG. Infective endocarditis: incidence and mortality in the North East Thames Region. Br Heart J 1988; 59: 62-68.
8. Chu VH, Cabell CH, Benjamin DK, Jr et al. Early predictors of in-hospital death in infective endocarditis. Circulation 2004; 109: 1745-1749.
9. Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet 2012; 379: 965-975.
10. Tornos MP, Permanyer-Miralda G, Olona M et al. Long-term complications of native valve infective endocarditis in non-addicts. A 15-year follow-up study. Ann Intern Med 1992; 117: 567-572.
11. Tornos P, Sanz E, Permanyer-Miralda G, Almirante B, Planes AM, Soler-Soler J. Late prosthetic valve endocarditis. Immediate and long-term prognosis. Chest 1992; 101: 37-41.
12. Fernandez-Hidalgo N, Almirante B. [Infective endocarditis in the XXI century: epidemiological, therapeutic, and prognosis changes.]. Enferm Infecc Microbiol Clin 2012; 30: 394-406.
13. Tran CT, Kjeldsen K. Endocarditis at a tertiary hospital: reduced acute mortality but poor long-term prognosis. Scand J Infect Dis 2006; 38: 664-670.
14. Heiro M, Helenius H, Hurme S et al. Long-term outcome of infective endocarditis: a study on patients surviving over one year after the initial episode treated in a finnish teaching hospital during 25years. BMC Infect Dis 2008; 8: 49.
15. Martinez-Selles M, Munoz P, Estevez A et al. Long-term outcome of infective endocarditis in non-intravenous drug users. Mayo Clin Proc 2008; 83: 1213-1217.
16. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-638.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
18. Baddour LM, Wilson WR, Bayer AS et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111: e394-e434.
19. Habib G, Hoen B, Tornos P et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009; 30: 2369-2413.
20. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16: 9-13.
21. Duval X, Delahaye F, Alla F et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol 2012; 29: 1968-1976.
22. Fowler VG Jr, Miro JM, Hoen B et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005; 293: 3012-3021.
23. Thuny F, Avierinos JF, Habib G. Changing patterns in epidemiological profiles and prevention strategies in infective endocarditis: from teeth to healthcare-related infection. Eur Heart J 2010; 31: 1826-1827.
24. Fernandez-Hidalgo N, Almirante B, Tornos P et al. Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital - prospective analysis of referral bias and influence of inadequate antimicrobial treatment. Clin Microbiol Infect 2011; 17: 769-775.
25. Botelho-Nevers E, Thuny F, Casalta JP et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med 2009; 169: 1290-1298.
26. Lalani T, Cabell CH, Benjamin DK et al. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation 2010; 121: 1005-1013.
27. San Roman JA, Lopez J, Revilla A et al. Rationale, design, and methods for the early surgery in infective endocarditis study (ENDOVAL 1): a multicenter, prospective, randomized trial comparing the state-of-the-art therapeutic strategy versus early surgery strategy in infective endocarditis. Am Heart J 2008; 156: 431-436.
28. Kang DH, Kim YJ, Kim SH et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 2012; 366: 2466-2473.
29. Kiefer T, Park L, Tribouilloy C et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA 2011; 306: 2239-2247.
30. Delahaye F, Rial MO, de Gevigney G, Ecochard R, Delaye J. A critical appraisal of the quality of the management of infective endocarditis. J Am Coll Cardiol 1999; 33: 788-793.
31. Muhlestein JB. Infective endocarditis: how well are we managing our patients?J Am Coll Cardiol 1999; 33: 794-795.
32. Bannay A, Hoen B, Duval X et al. The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results?Eur Heart J 2011; 32: 2003-2015.
33. Castillo JC, Anguita MP, Ramirez A et al. Long term outcome of infective endocarditis in patients who were not drug addicts: a 10year study. Heart 2000; 83: 525-530.
34. Netzer RO, Altwegg SC, Zollinger E, Tauber M, Carrel T, Seiler C. Infective endocarditis: determinants of long term outcome. Heart 2002; 88: 61-66.